Infantile spasms associated with a histamine H1 antagonist

Neuropediatrics

Volumn 29, Issue 6, 1998, Pages 320-321

  Yasuhara, A ^a   Ochi, A ^b   Harada, Y ^b   Kobayashi, Y ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Histamine H1 antagonist; Infant; Infantile spasms; Ketotifen; Seizure

Indexed keywords

CLONAZEPAM; CORTICOTROPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; VALPROIC ACID;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; BRONCHITIS; CASE REPORT; EPILEPSY; HUMAN; INFANT; INFANTILE SPASM; MALE; PRIORITY JOURNAL;

ELECTROENCEPHALOGRAPHY; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; KETOTIFEN; MALE; SPASMS, INFANTILE;

EID: 0032423731     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973585     Document Type: Article

References (5)

1. Bernstein, E., Diskant, B. M. Phenylpropanolamine: a potentially hazardous drug. Ann. Emerg. Med. 11, 311-315 (1982).
2. Cacabclos, R. Histaminergic regulation of the neuroendocrine system (NES). In: Histaminergic Neurons: Morphology and Function. Watanabc, T., Wailo, H. (Eds.). CRC Press: New York, 241-270 (1991).
3. Churchill. J. A., Gammon, G. D. The effect of antihistaminic drugs on convulsive seizures. J. Amer. Med. Assoc. 141, 18-21 (1949).
4. Kh'iranta, T., Tiiomislo, L., Airaksinen, E. M. Histamine in cerebrospinal fluid of children with febrile convulsions. Epilepsia 30, 270-280 (1995).
5. Mueller, M. S. Phenylpropanolamine, a nonprescription drug with potentially fatal side effects. N. Engl. J. Med. 308, 653 (1983).